Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD
To access this article, please choose from the options below
PII: S0272-6386(04)00376-2
doi:10.1053/j.ajkd.2004.01.019
© 2004 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
